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ABSTRACT 
Arteriogenic Revascularization Does Not Induce Vascular Function Impairment 
Matthew Yocum 
 
Functional hyperemia and arteriolar vasodilation are impaired with chronic ischemia. We 
sought to examine the impact of chronic ischemia on collateral artery function. For this 
we used two hindlimb ischemia models to dissect the impact of different repair processes 
on collateral function. Ligation of the femoral artery increases shear stress in the 
muscular branch and results in outward remodeling and arteriogenesis. In contrast, 
resection of the femoral artery proximal to the muscular branch induces blood flow 
divergence and neutral remodeling along with expectedly greater hypoxia and 
inflammation. On day 14 after each surgery the diameter of the muscular branch was 
measured using sidestream dark field (SDF) imaging before and after gracilis muscle 
stimulation. A slight, but not statistically significant, impairment in functional 
vasodilation was observed in ligated mice (69±10% average diameter increase compared 
to 74±7% average diameter increase). Resected mice exhibited slightly (not statistically 
significant) enhanced collateral artery functional vasodilation (104±16% average 
diameter increase) but were also refractory to the restoration of resting vascular tone 
following the cessation of stimulation. Outward remodeling did not significantly impair 
vascular function, whereas neutral remodeling and tissue hypoxia induced impaired 
vascular tone. 
 
 
 
Keywords: Vascular Function, Ischemia, Arteriogenesis, Mouse, SDF Imaging, Gracilis, 
Peripheral Artery Disease. 
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I. INTRODUCTION 
 
 
1.1. CIRCULATORY FUNCTION AND DYSFUNCTION 
The circulatory system consists of the heart as well as the arteries, veins and capillaries 
that perfuse all bodily tissues to deliver key metabolic nutrients like oxygen and glucose 
(Figure 1A) [1]. The most important function of the circulatory system is to transport 
these nutrients to functioning tissues and deliver metabolic waste to the liver, lungs or 
kidneys for excretion or degradation (the circulatory system thus plays an important role 
in homeostasis including temperature and pH control) [1]. This nutrient/waste exchange 
is mediated by the heart, which pumps deoxygenated blood to the lungs, where carbon 
dioxide is released and oxygen binds to hemoglobin-containing red blood cells (Figure 
2A) [1]. After leaving the lungs, oxygenated blood is then transported to the heart and 
pumped through the arteries to the systemic tissues (Figure 1B) [1]. The exchange of 
metabolites such as oxygen, carbon dioxide and glucose occurs via convection and 
diffusion (promoted by hydrodynamic and osmotic pressure gradients) and is facilitated 
by the thin, single cell thick, capillary walls where exchange occurs (Figure 1C) [2]. This 
thin wall between the tissues or alveoli in the lungs and the circulating blood assists 
metabolite diffusion, because the flux of migrating gaseous or aqueous molecules is 
inversely related to the distance of the crossed barrier [2]. Further, diffusion and 
convection, the mechanisms of nutrient exchange in the tissues, are mediated by a 
balance between blood pressure (which also promotes blood filtration in coordination 
with the lymphatic system) and osmotic pressure (Figure 2B) [1, 2]. Coordinating these 
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processes to maintain proper nutrient trafficking and vascular function is vital for the 
health of all tissues in order to sustain sufficient ATP production required for cellular 
activity and viability [1, 2]. It is also imperative that the circulatory system not only 
supply sufficient blood flow to tissues during rest, but that it is also amenable to adjusting 
blood flow to specific tissues as metabolic demands shift [3-5]. For example, after a meal 
the digestive system, particularly the intestine, requires an increase in blood flow to 
facilitate digestion and absorption. Normally the intestine receives 20% of the cardiac 
output, however, after a meal this amount increases 2-fold [6]. 
 
Mechanistically, localized blood flow control is mediated primarily through arterial 
lumen expansion and contraction (vasodilation and vasoconstriction, respectively) [3, 4]. 
These adjustments in arterial diameter result in large changes in blood flow, because 
blood flow is directly related to the lumen radius to the power of 4 (Poisseuille’s Law, 
Appendix A) [7]. Thus, vasodilation and vasoconstriction are effective methods for 
specific tissue blood flow control. Overall, blood and nutrient delivery are affected 
locally by arterial expansion/contraction and diffusion distance between the tissues and 
blood, as well as generally by cardiac output. Given the important functions of the 
circulatory system, local vascular complications that affect arterial relaxation/constriction 
or that increase tissue capillary distance can be especially detrimental to systemic health, 
because they inhibit proper nutrient delivery [1-5].  
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Figure 1. Circulatory system overview. A broad representation of the reach of the circulatory system (A) 
[8]. A simplistic diagram of the primary circulatory pathway in the human body (B) [9]. A basic illustration 
of arteriole, venule and capillary anatomical structure (C) ([10], permission by GNU Free documentation 
License). 
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Figure 2. Nutrient exchange. Gaseous exchange in the lungs (A) ([11], Image provided courtesy of 
HowStuffWorks.com) . Fluid exchange in tissue capillaries (B) [12]. 
 
Circulatory system control and efficacy can be impaired through various mechanisms. 
For example, edema can undermine nutrient exchange between the tissues and capillaries 
as the interstitial fluid volume expands, increasing the distance and delaying the speed of 
diffusion [13]. Vascular dysfunction can also be caused by narrowing or occluding of 
arteries, which induces insufficient blood delivery or ischemia [14]. This will be a key 
point, as this study will aim to identify the reason(s) for which ischemic insult abrogates 
normal vasodilation and vasoconstriction mechanisms. In human extremities this blood 
supply impairment (ischemia) can result in peripheral artery disease (PAD), which is of 
particular importance to this research [14]. Although this review of circulatory function is 
general in scope, it should be apparent that the circulatory system must negotiate varying 
metabolic demands within the body in an attentive and complex manner. 
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1.2. PERIPHERAL ARTERY DISEASE 
 
As stated above, PAD is caused by insufficient blood flow to affected muscles and other 
tissues in the extremities. This reduction of blood flow to peripheral tissues is due to 
occlusion and narrowing of the vascular luminal space [15]. In most cases this 
obstruction is due to atherosclerosis (Figure 3), where extracellular cholesterol will build 
up along damaged/torn sections of arterial walls and be covered in a thin layer of fibrotic 
tissue [16]. This stenosis reduces volumetric blood flow via Poisseuille’s Law. The 
resultant blood flow insufficiency (ischemia) is a detriment to the health of the 
extremities and must be ameliorated by vascular growth or by breaking apart or 
minimizing occlusions [15]. Further, while the resting blood supply is affected by this 
condition, vascular function (blood flow control) is also impaired (as previously 
mentioned). Furthermore, blood flow control is also important to patient health, as the 
earlier discussion would suggest [17]. Patients suffering from this condition commonly 
experience claudication (limb fatigue during activity) and pain in their feet while resting, 
specifically in the arch, ball or toes, and if the condition is not correctly treated, the 
symptoms may progress to include ulceration and tissue necrosis [18]. The latter 
symptoms of this disease are caused by total arterial occlusion in the extremity, a 
condition termed critical limb ischemia (CLI) [19]. The patient population affected by 
this disease (PAD) and these symptoms includes 10-25% of patients over the age of 55, 
affecting 8 million people in the United States [16, 18]. Coronary artery disease, a related 
malady also caused by atherosclerosis, is the most prevalent form of heart disease and the 
leading cause of death for men and women in the United States [20]. In fact, PAD is a 
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strong predictor, risk factor, and co-morbidity for CAD [21]. In one study 79% of 
patients with PAD also had CAD [21]. Total occlusion of coronary arteries results in a 
myocardial infarction or heart attack [20]. Furthermore, patients with CLI have an 
enhanced risk (300% greater) to develop a myocardial infarction and stroke when 
compared to patients with only irregular claudication [22].  
 
 
Figure 3. Atherosclerosis. The progression of chronic atherosclerosis in blood vessels to ischemia and 
complete arterial occlusion by blood clotting [23]. 
 
 
In patients presenting with early stage PAD and irregular claudication the current 
standard of care is conservative management with aspirin and statin drugs treatment [24]. 
Vascular growth promoting therapies are still being evaluated for potential benefit in 
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alleviating ischemia and improving patient prognosis [25]. Should the disease progress to 
a more severe stage, as in CLI, surgical bypass, angioplasty and stent implantation are 
common treatment options [26]. If skeletal muscle perfusion and vascular function are 
not adequately ameliorated the disease may advance further and require limb amputation 
as gangrene and necrosis worsen [19]. This extreme intervention is often required when 
there has been multilevel total arterial occlusion and the previous interventions have 
failed [19]. The incidence of critical limb ischemia is approximately 500 to 1000 persons 
per million per year, with an even higher prevalence of cases among patients with 
diabetes [27].  
 
To reduce the prevalence and minimize the disease progression through the development 
of better treatment options and therapeutic strategies it is imperative that disease 
mechanisms be further elucidated. Additionally, by expanding the knowledge of PAD 
pathogenesis, CAD pathology may be further understood given the overlapping etiology 
of the two conditions. Furthermore, it will be important to understand normal vascular 
growth and repair processes that work to ameliorate the associated ischemia (insufficient 
blood flow) and may play a role in ischemia-induced vascular dysfunction. In general, the 
process by which blood flow is salvaged is known as revascularization [28]. 
Revascularization is a broad term that can refer to surgical intervention, angiogenesis 
(sprouting of capillaries), or arteriogenesis (outward remodeling of arterioles) (two 
processes to be more vigorously discussed later) [28, 29]. As suggested vascular function 
is also important to tissue health following ischemic recovery. Developing an 
understanding of how angiogenesis, arteriogenesis and vascular function preservation 
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relate (specifically, whether ischemia-induced vascular dysfunction is caused by either 
repair process) and lead to successful revascularization will be key to identifying 
efficacious treatments for PAD. A significant amount of information is already known 
about angiogenesis and arteriogenesis, knowledge that will aid analysis of this study of 
ischemia and revascularization. 
 
 
1.3. MECHANISMS OF VASCULAR GROWTH AND FUNCTION 
1.3.1. Arteriogenesis 
During ischemia, collateralization (arteriogenesis) is generally the most effective 
mechanism for blood flow recovery as it has the unique potential to fully compensate the 
blood flow lost from an occluded artery [30]. Collateralization describes the outward 
remodeling of linked arterioles into conduit arteries [31]. Chronic increases in shear 
stress have been demonstrated to induce arteriole growth and outward remodeling [32]. 
The mechanisms responsible for shear-stress-induced arteriogenesis, while not entirely 
understood have been elucidated in various vascular investigations. An enhancement of 
arterial shear stress due to an arterial occlusion, for example, causes endothelial swelling, 
inflammation and randomized orientation (as opposed to the usual orientation in the 
direction of blood flow) [30]. These intimal (inner layer of artery or endothelial layer) 
changes result in increased intercellular permeability and inflammation, as evidenced by 
red blood cells, platelets and plasma constituents seeping through the vessel wall [30]. 
Additionally, the shear stress stimulus activates endothelial cells (Figure 4) to release key 
arteriogenic cytokines [30]. Intracellular adhesion molecule (ICAM-1), vascular cell 
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adhesion molecule (VCAM-1) and monocyte chemoattractant protein (MCP-1) are up-
regulated in endothelial cells following shear stress stimulation [33]. These soluble 
molecules promote monocyte migration and adhesion to the affected collateral vessels 
within 12hrs of arterial occlusion [30, 33].  
 
 
Figure 4. Arterial layers and outward remodeling mechanisms. The anatomical structure of an arteriole (A) 
[34]. Mechanisms underlying arteriogenesis (B) [35]. 
 
The monocytes and macrophages recruited to this vasculature site promote the previously 
described inflammatory response and release growth factors including basic fibroblast 
growth factor (bFGF) and tumor necrosis factor-alpha (TNF!), which act to initiate 
cellular proliferation [33, 36]. Specifically, endothelial cells in the intima and smooth 
muscle cells (SMCs) constituting the media of collateral arterioles begin to proliferate 
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22hrs following an arterial occlusion [37]. Further, SMCs proliferate to form a 
synthetically active (producing large amounts of growth promoting factors/proteins) 
neointima layer, which works to potentiate SMC growth and vessel remodeling [30, 38]. 
This layer is maturely developed in remodeled coronary arteries, but less developed in the 
periphery [30]. Another process vital for arterial remodeling is the proteolysis of the 
external and internal elastic lumina and basement membranes as well as apoptosis of 
SMCs, in order to expand the arterial lumen (equivalent to knocking down a wall to make 
a larger room) [30]. Macrophages and activated fibroblasts in the adventitia secrete 
matrix metalloproteinases (MMPs), which act to aid the remodeling process through 
proteolysis of the elastic lamina, which promotes migration of SMCs and arterial lumen 
expansion [30].  
 
In general, SMC proliferation is the primary mechanism for arterial remodeling [30]. This 
SMC expansion is induced through increases in shear stress, which activate endothelial-
dependent pathways (previously described) and cause endothelial cell deformation [30]. 
Endothelial cell (EC) changes and the resultant EC release of various arteriogenic factors, 
following the specified deformation, are thought to be the primary mediators for 
remodeling. Nitric oxide (NO) and vascular endothelial growth factor (VEGF) have been 
implicated as promoters of collateralization likely induced by endothelial, shear-stress-
activated signaling [39-41]. However, the arteriogenic sources and mechanisms for these 
factors have yet to be fully elucidated [30]. For example, endothelial nitric oxide synthase 
(eNOS) was long thought to be responsible for NO induced arteriogenisis when eNOS 
was observed to promote vasodilation during blood flow recovery, but was eventually 
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demonstrated to be an ineffective mediator for collateral growth [42]. Still, multiple 
experiments have demonstrated that inhibition of NO is detrimental for collateral growth, 
suggesting that the key arteriogenic source for NO may be other NO donors such as 
inducible nitric oxide synthase (iNOS) [30, 40]. Much about arteriogenic mechanisms has 
been elucidated (as previously described), however, the role of NO or the specific 
mechanistic deviations from other repair processes have not been determined. 
 
1.3.2. Angiogenesis 
Although angiogenesis is not capable of renewing blood flow to the same degree as 
arteriogenesis, this distinct vascular growth mechanism has also been extensively 
researched for potential applications in PAD, cancer, age-related macular degeneration 
(AMD) and other vascular disorders [43]. Angiogenesis is described as capillary 
generation (Figure 5) and often occurs when tissues are subjected to a hypoxic 
environment (oxygen deficient) because of severe ischemia or other reasons. Newly 
formed capillaries function to supply blood to nutrient deficient (due to ischemia) tissues. 
The lack of oxygen in ischemic tissues activates various signaling pathways that up-
regulate key soluble factors required for endothelial cell migration, capillary sprouting 
and formation [44]. Angiogenesis inducing factors such as vascular endothelial growth 
factor (VEGF), placenta growth factor (PIGF) and NO have been identified through the 
use of transgenic and knockout mice [45, 46]. The most extensively examined factor, 
VEGF, has been shown to modulate endothelial cell function (protein/cytokine synthesis) 
and migration in the formation of new capillaries [47, 48]. Specifically, VEGF-C has 
been shown to not only induce the production of chemo-attractants to mediate endothelial 
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cell migration, but also induces endothelial cells to release NO and increase vascular 
permeability to facilitate migration [49].  
 
 
Figure 5. Angiogenesis of blood vessels [50]. 
 
There has been significant research done to identify angiogenic factors because these 
factors are also used by cancerous tumors to induce required blood perfusion. For this 
reason, the identification and targeting of these factors have been beneficial in slowing or 
ceasing tumor growth [51, 52]. As discussed earlier, understanding angiogenesis is also 
important for the treatment of ischemia and peripheral artery disease, because inducing 
angiogenesis could facilitate the expansion of capillary networks and reduce diffusion 
distances thereby promoting nutrient exchange to hypoxic tissues.  
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1.3.3. Blood Flow Control Pathways 
While the aforementioned vascular growth mechanisms are critical for revascularization, 
recovery of vascular function is also important to insure the restoration of adequate tissue 
health. For example, the ability for remodeled vessels to vasodilate (luminal expansion) 
or vasoconstrict (luminal narrowing) according to downstream tissue demands is 
imperative to tissue function. As can be seen from Poiseuille’s equation (Appendix A), 
these mechanisms can be used in tandem to effectively control blood flow (Figure 6). 
Specifically, in the case of ischemia, especially acute ischemia, vasodilation is utilized 
 
 
Figure 6. Arteriole blood flow control through vasodilation and vasoconstriction [53]. 
 
to return arterial blood flow to the level required by the tissue metabolism. For example, 
there are instances when arteries become occluded for a short time period and following 
the removal of this obstruction the downstream tissue responds through vasodilation to 
restore normoxia to tissues distal to the ischemic event, in a response known as reactive 
hyperemia [13]. Similarly, during exercise and increased skeletal muscle metabolism, 
arterioles will dilate to increase blood flow to exercising muscles in a process known as 
functional hyperemia [13]. 
 
Vasodilation Vasoconstriction 
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Many factors that control arterial blood flow (i.e. during hyperemic events), such as 
various vasodilators and vasoconstrictors, have been identified through the use of various 
animal models. Nitric oxide (NO) is a significant vasodilator shown to play a key role in 
vasodilation as well as angiogenesis and arteriogenesis [46]. Additionally, acute increases 
in arterial shear stress due to blood flow has been shown to cause arterial vasodilation [5]. 
Moreover, arterial shear stress and vasodilators including acetylcholine and bradykinin 
can mediate dilation through the activation of eNOS to produce NO [5, 46]. 
Alternatively, various vasoconstrictors have also been identified, such as norepinephrine, 
vasopressin and angiotensin II [7]. These factors constitute some of the pathways for 
vascular diameter modulation. However, in conditions of chronic ischemia blood flow 
control mediated by vasodilators such as adenosine and bradykinin as well as 
vasoconstrictors such as norepinephrine is attenuated [5, 17]. The mechanism by which 
these vaso-active agents fail during chronic ischemia would aid in our understanding and 
treatment of peripheral artery disease, because even if new treatments are able to promote 
vascular growth it remains imperative that these new or remodeled vessels be able to 
function according to the needs of skeletal muscle metabolism; proper vascular function 
is vital for adequate tissue function. 
 
1.3.4. Interrelation Between Vascular Growth and Function During Ischemic Repair 
To bring these concepts together let’s quickly review repair progression following 
ischemia. After an ischemic insult (i.e. PAD) affected tissues normally respond to 
ameliorate insufficient blood flow by promoting vascular growth through arteriogenesis 
or angiogenesis, depending on their physiological environment (i.e. high shear stress or 
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hypoxia). For reasons that we aim to discover, vascular function (ability for 
vasodilation/vasoconstriction) is impaired following ischemic repair [5, 17]. Certain 
arteriogenic or angiogenic physiological settings are expected to be the cause of this 
ischemia-induced vascular dysfunction. In this research we test the hypothesis that 
arteriogenic repair induces blood flow control impairment. To test this hypothesis we will 
utilize commonly used animal models of ischemia and revascularization. 
 
 
1.4. MOUSE MODELS OF HINDLIMB ISCHEMIA 
Animal models have often been used to analyze ischemic repair. One model that is 
compatible with both the project needs (in respect to ability to test our hypothesis) and 
facilities available (accommodations appropriate for animal housing, experimentation and 
survival), is a mouse model of hindlimb ischemia. In general, this model involves 
obstruction of hindlimb vasculature to cause insufficient blood flow and prompt an 
ischemic response. Within this animal model there are multiple surgical models (different 
sites or methods of arterial occlusion) with which we can utilize to induce distinct 
ischemic settings in the hindlimb. 
 
To tease apart the potential reasons for vascular dysfunction it would be useful to use 
multiple surgical models for ischemia in which revascularization occurs under distinct 
physiological conditions. The previous studies, which observed impaired vasodilation to 
both metabolic  and pharmacological stimuli were done using one rat model of hindlimb 
ischemia in which the iliac artery was ligated and vascular function was evaluated in the 
16 
lower hindlimb [5, 17]. Following ischemia-inducing surgery there are multiple factors 
that could influence vasculature dysfunction such as inflammation, oxygen delivery and 
average blood flow. In the previously referred to experiments involving iliac artery 
ligation, vascular function in the lower limb was evaluated and observed to be impaired 
under conditions of significant hypoxia, ischemia and inflammation [5, 17].  
 
It remains unclear which specific factors influenced blood flow control impairment. So, 
by using two distinct mouse models of hindlimb ischemia (which create two distinct 
tissue environments) we may be able to identify which factors are correlated with the loss 
of appropriate vascular control. In one of the surgical models we will use, involving 
ligation of the femoral artery, it is anticipated that blood flow will be high, oxygen 
delivery will be normal and inflammation will be less severe in collateral arterioles than 
in the other model (involving resection of the femoral artery), where tissues are expected 
to be more hypoxic and ischemic (models will be more rigorously discussed later). In 
general, the idea is to examine vascular function of an arteriole “in series” and “out of 
series” of diverged blood flow following ischemia induced by arterial occlusion (Figure 
7). To clarify, an arteriole “in series” with diverged blood flow experiences high shear 
stress, inducing outward remodeling/arteriogenesis, while an arteriole “out of series” 
experiences normal-low blood flow (as a major source of blood flow is cut off) and 
reduced collateralization (arteriogenesis). In another way, one model will examine blood 
flow control under a distinctly arteriogenic revascularization environment, while the 
other will evaluate the same vascular response in non-arteriogenic promoting conditions. 
To reiterate, the creation of distinct ischemic settings through the use of two surgical 
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models should help to tease apart the underlying (potentially repair-related) causes of 
ischemia-induced vascular dysfunction. By identifying these causes, this study hopes 
pinpoint potential therapeutic targets for patients with PAD experiencing inadequate 
blood flow control and claudication. 
 
  
Figure 7. Generalized juxtaposition of surgical models. In general the idea is to examine the 
revascularization conditions of conduit arteries (brackets, gracilis arteries in the hindlimb) following 
distinct occlusion scenarios of the main blood supplying vessel (top vessel, femoral artery in the hindlimb). 
One model isolates arteries “out of series” (within green brackets) with diverged blood flow following 
ischemia inducing arterial occlusion (designated by crosses) (A). Another model examines arteries “in 
series” (within purple brackets) with diverged blood flow following ischemia inducing arterial occlusion 
(B) (adapted from [18]).  
 
1.4.1. Distinctions Between Animal Ischemia Models and PAD Etiology 
The mouse models used were not meant to model the exact etiology of PAD, but to 
model one aspect of the disease pathology, specifically chronic limb ischemia. Modeling 
and examining vascular repair/function in the context of ischemia should prove useful in 
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the development of treatments for PAD, as insufficient blood flow is a significant source 
for poor tissue health in patients suffering from this disease. Even more, these models 
provide a simplified ischemic setting to examine dysfunction development. It is 
imperative to describe the differences between the mouse hindlimb ischemia models and 
PAD such that model limitations are elucidated and understood. 
 
As discussed earlier, the models aim to parallel ischemic conditions in the extremities of 
patients with PAD. However, the causes for the ischemic conditions in the models are 
significantly different than those inducing ischemia in PAD. Ischemia with PAD is a 
result of atherosclerosis, which occurs chronically, via gradual build-up of plaque and 
narrowing of the arteries over many years [15]. Complete occlusion of arteries often 
results in limb necrosis without proper treatment (10-40% have primary amputations and 
there is a mortality rate of 40-70% in 5 years) [54]. In contrast, both of the mouse arterial 
occlusion models do not occur gradually, as the femoral artery is completely occluded 
within the span of a few surgical motions.  
 
Further, as stated above, complete arterial occlusion in the human disease likely results in 
limb necrosis with conservative (non-surgical) treatment (within 1 year 95% of surviving 
patients with tissue loss, not treated surgically require amputation) based on the 
population of patients that present in the hospital (there is likely an uncharacterized 
subset of patients that do not present in a hospital and are able to revascularize), whereas 
in the mouse, hindlimb revascularization occurs and the mouse is able to recover over a 
period of 2-4 weeks without any intervention or treatment [42]. This disparity is likely 
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exaggerated by the presence of co-morbidities (i.e. heart disease, obesity, etc.) in the 
human condition. The gradual arterial narrowing of atherosclerosis also results in a 
slower impairment of blood flow and progression of hypoxia, which may result in a 
different timeline for vascular repair. Additionally, atherosclerosis is often found at 
multiple vascular sites in the circulatory system of the extremities [15]. However, the 
surgical mouse models result in arterial occlusion at one point in the femoral artery. 
Hence, while both PAD and the hindlimb ischemia models induce ischemia in the 
extremities (hindlimb), the mechanisms that each insult utilizes to affect that change are 
distinct. Furthermore, it is imperative to understand those differences such that it is 
possible to place any knowledge gained about vascular repair under ischemic conditions 
into the correct context. Knowing this, the mouse ischemia models can still provide 
important information in regards to vascular repair, as we expect to examine the process 
of revascularization and how this repair process may influence recovery of vascular 
function following ischemic insult. 
 
The two mouse models of hindlimb ischemia focus on the medial aspect of the upper 
hindlimb under various methods of femoral artery occlusion. Revascularization following 
each occlusion model was evaluated in the vasculature of the upper hindlimb, specifically 
the muscular branch (for an overview of the hindlimb vascular structure prior to the 
upcoming more focused examination of each model see Figure 8). 
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Figure 8. Arterial map of rabbit hindlimb (rats, mice and other animals have analogous structures) (adapted 
from [48]). 
 
1.4.2. Femoral Artery Ligation Model 
The first hindlimb ischemia model used to examine the revascularization of arteries 
feeding the gracilis muscle involved the ligation of the femoral artery downstream to the 
muscular branch and deep femoral arteries (Figure 8, 9). This arterial occlusion model 
induces both blood flow changes and repair processes that we hope to relate to PAD. 
First, there will be a divergence of blood flow that previously traveled through the 
femoral artery and to the saphenous artery [42, 55]. Instead, this blood will not be able to 
flow through the femoral artery and will flow through the deep femoral and muscular 
branch arteries, in addition to alternative conduits in the deep hindlimb muscle [42, 55].   
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Figure 9. Diagram of the femoral artery ligation model. The red arrows show blood flow divergence 
following the surgery. 
 
This arterial insult affects different areas of the mouse hindlimb in distinct ways. 
Perfusion of the lower hindlimb or the calf is significantly decreased (Figure 10), because 
following femoral artery ligation there are essentially no more large arteries to feed this 
part of the extremity. Due to this severe ischemia, oxygen and other nutrients are not 
easily transported to the lower limb and the affected tissues experience hypoxia and 
inflammation, environmental factors that promote angiogenesis [42, 55]. Alternatively, 
the upper hindlimb likely experiences mild hypoxia to normoxia as blood flow is 
generally increased, because of the blood flow being directed away from the femoral 
occlusion (see Figures 9 and 10). An increase in wall shear stress due to the elevated 
blood flow will have both acute and chronic consequences. A sharp increase of shear wall 
stress will result in arterial vasodilation mediated through the activation of endothelial 
nitric oxide synthase (eNOS) (to produce NO) [5].Hence, an acute outcome will be 
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vasodilation due to blood flow divergence and increased shear wall stress. As this 
occlusion will be permanent, chronic increases in wall shear stress will also be relevant to 
physiological recovery from the ligation surgery. As previously stated long lasting 
increases in shear wall stress induce arteriogenesis (refer back to Figure 5) [30, 32, 33]. 
Thus, arteries perfusing muscles of the upper hindlimb (i.e. gracilis muscle) will 
outwardly remodel (Figure 11) and act as the primary mediators for blood flow recovery 
[55, 56]. This arteriogenic response as well as the relevant ligation-induced conditions 
(high shear stress, normoxia and modest inflammation) will be important to recall and 
contrast with the revascularization environment in the resection model. This juxtaposition 
will be important to illuminate the physiological causes for the impairment of vascular 
function following chronic ischemia and eventually improve our understanding of PAD. 
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Figure 10. Hindlimb perfusion changes following femoral artery ligation. Scanning Laser-Doppler 
perfusion images of blood flow changes in the right ischemic limb immediately following and 3 weeks 
following femoral artery ligation compared to the perfusion changes in the nonischemic left limb [55]. 
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Figure 11. Arteriogenesis following femoral artery ligation. Collateralization of gracilis arterioles in the 
hindlimb (rectangular box) following ligation on left and a picture of the non-ischemic hindlimb on the 
right (adapted from [32]). 
 
1.4.3. Femoral Artery Resection Model 
As mentioned, a resection model of hindlimb ischemia will also be used in order to 
examine distinct revascularization conditions. In this resection model the femoral artery 
is removed from just proximal to the muscular branch artery to half way between the 
knee and the heel or soon after the saphenous artery branch point (Figure 12). Branching 
arteries are either cut or cauterized as the majority of the superficial femoral artery is 
removed. Based on previous research, this model impedes the majority of blood flow to 
the hindlimb, as blood flow can no longer be diverged to the muscular branch or deep 
femoral arteries directly from the femoral artery [44]. As in the femoral artery ligation 
model the lower and upper hindlimb experience and react to distinct tissue environmental 
conditions. In this model the tissues in the lower leg are again subjected to a hypoxic and 
ischemic environment similar to the femoral artery ligation model [44]. Further, 15 days 
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following both the femoral artery ligation and resection models the perfusion of the lower 
ischemic hindlimb is approximately 60% of the nonischemic limb [44, 55]. As a result, 
angiogenesis is significantly increased in the lower hindlimb of this model as well, since 
it has been demonstrated that hypoxia is a crucial driving factor for angiogenesis [57]. In 
the upper hindlimb, following resection of the femoral artery, blood flow will primarily 
come from other, smaller feed arteries, such as the medial circumflex, which will supply 
the muscular branch artery and gracilis microcirculation with needed nutrients [58].  
 
 
Figure 12. A diagram of the femoral artery resection model for hindlimb ischemia (the superficial femoral 
artery section between each ligation site was removed and one ligature was left in). 
 
 
Following surgery, arteriogenesis will occur in the medial aspect of the upper hindlimb. 
However, it is anticipated that this remodeling will occur to a lesser extent in the gracilis 
muscles when compared to the ligation model and furthermore repair will occur under 
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different conditions. For example, blood flow and thus shear stress in the arteries 
perfusing the upper hindlimb (specifically the gracilis muscles) should be reduced when 
compared to the same vessels following arterial ligation. Further, tissues of the upper 
hindlimb should be exposed to greater hypoxia in the femoral resection model. Relatively 
more severe hypoxia in the upper hindlimb following femoral artery resection should be 
expected based on the extensive arterial excision and insult to hindlimb perfusion when 
compared to the blood flow increase in the ligation model, as blood is redirected to the 
gracilis muscles directly through the muscular branch (impossible following resection) 
(Figure 11). A simple ligation of the femoral artery proximal to the muscular branch 
artery was not used due to the concern that blood flow through the muscular branch may 
be salvaged (inhibiting the contrast between models which is vital for comparison) by 
other feed arteries (the gracilis arcade), a consequence that is hindered by thorough 
excision of the majority of the femoral artery.  
 
Separately, this model is also different, in that the extensiveness of the surgery should 
require a higher degree of invasive dissection, as the artery vein pair must be dissected 
from muscle, nerve and other blood vessels along a longer length. Given this and the 
more severe hypoxic and ischemic insult, it is expected that this surgery should induce 
more significant and ubiquitous inflammation of the hindlimb, promoting angiogenic 
revascularization. The fact that the resection model has stark distinctions in ischemic 
tissue conditions allows for the examination of vascular function following unique repair 
processes (predominantly arteriogenic vs. non-arteriogenic revascularization).  
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Using both the femoral artery ligation and resection models, the aim of this study will be 
to examine the role arteriogenic revascularization processes/conditions (especially shear 
stress) may play in blood flow control impairment following chronic ischemia. The 
ultimate goal is to identify the mechanisms for vascular dysfunction following ischemia 
and utilize that knowledge to treat similar blood flow control impairments in PAD 
patients. The development of new technologies is aiding that aim. Unique microscopes 
that can evaluate blood flow in different ways as well as sensors to detect concentrations 
of key soluble factors such as NO and oxygen are helping to progress our understanding 
of revascularization mechanisms. In this project a novel video microscope with the 
capability to measure vasodilation in large arterioles and blood flow through complex 
microcirculation was used to evaluate vascular growth and vascular function following 
chronic hindlimb ischemia. 
 
 
1.5. SIDESTREAM DARK FIELD IMAGING 
Sidestream dark field (SDF) imaging technology was used to asses the vascular repair 
process. This technology was developed following the advent of Orthogonal Polarization 
Spectral (OPS) imaging (Figure 14) [59]. Although analysis of microcirculatory function 
both clinically and experimentally is useful, investigation of the microcirculation was 
limited by the size and narrow scope of previous devices (prior to OPS) [59]. However, 
with the development of OPS and SDF imaging technology the size of vascular imaging 
devices has shrunk while the capabilities have expanded [59]. In SDF imaging, photons 
are emitted at a wavelength that is absorbed by hemoglobin molecules [59]. Meanwhile, 
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photons not absorbed by hemoglobin scatter and reflect back to a detection lens (Figure 
13) [59]. Light detected in this fashion appears light on the video, while blood vessels, 
which contain hemoglobin appear dark [59]. This creates a contrast, which allows for the 
distinction and visualization of red blood cell (hemoglobin is a primary constituent) 
carrying vessels (veins and arteries) [59]. Not only can these vessels be visualized, but 
blood flow can also be measured in many of the vessels utilizing computer software [59]. 
Clinically, this technology along with OPS imaging has seen increased use, as it has 
become a useful diagnostic tool for various diseases [60, 61]. For our purposes, the SDF 
imaging microscope was used to evaluate vascular growth and function following 
revascularization of the muscular branch artery (which feeds the gracilis muscles) in vivo, 
by measuring changes in arterial diameter.  
 
 
Figure 13. Diagram of SDF imaging mechanism. The SDF video microscope with and outer illuminating 
ring and a separate inner lens system. The microscope excites hemoglobin, absorbs emitted photons and a 
computer converts that information to a digital video (adapted from [59]). 
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Figure 14. Digital video data examples from OPS and SDF imaging (adapted from [62]). 
 
 
1.6. OBJECTIVES AND HYPOTHESES 
Experimentally, this study aims to examine collateral artery function following 
revascularization under arteriogenic and non-arteriogenic-inducing ischemic conditions. 
It is expected that this investigation will direct future research to the likely physiological 
factors (i.e. hypoxia, inflammation, etc.) that influence vascular function impairment. 
More specifically, there were three primary objectives that were set to direct this research 
to that ultimate goal: 
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1. Establish a consistent protocol for the SDF imaging intravital microscope to 
examine muscular branch arterial changes during functional hyperemia induced 
by gracilis stimulation. The SDF microscope had not been used to image mouse 
vasculature in this way. Thus, there was a significant amount of troubleshooting 
early in the experiment. 
2. Examine (using the established SDF imaging protocol) collateralization of the 
muscular branch artery two weeks after ischemic surgeries. This objective was 
established to validate a generally accepted concept based on previous research: 
femoral artery occlusion induces arteriogenesis in the upper hindlimb [55]. 
However, it would also be interesting to examine how collateralization of the 
muscular branch varies between the resection and ligation models. 
3. Examine vascular functional hyperemia following arteriogenic and non-
arteriogenic ischemic insult. The ultimate objective of this research, with the aim 
to direct future research. 
 
It was initially hypothesized that the ligation model would induce vascular dysfunction 
compared to both the non-ischemic and resected limbs due to elevated arterial shear-wall 
stress (in the ligation model). 
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II. METHODS 
 
 
 
2.1. HOUSING FOR MICE 
Male C57/B6 mice were housed in the Cal Poly vivarium, with four mice to a micro-
isolator cage. The room was maintained at 73±5.0°F and lights were on 12 hour 
light:dark cycles. Cages were changed at least once a week. Mice were provided food and 
water ad libitum in addition to the following enrichments: mouse house, nesting material, 
and plastic tube. During cage changes, lab members donned isolation outfits to preserve 
aseptic conditions. Further, mice were monitored on a daily basis, during which their 
health and any irregularities were recorded and/or addressed as necessary (see Appendix 
B). 
 
 
2.2. VASCULAR FUNCTION EXPERIMENTS ON MICE NOT SURGICALLY ALTERED 
Sidestream Dark Field imaging was used to study vascular function of the muscular 
branch in the mouse hindlimb (see Appendix C for experimental checklist). Experiments 
were performed on C57/B6 mice using isoflurane anesthesia. The mice were kept at a 
temperature of 35±1.0°C using a rectal-temperature controlled heating pad (Temperature 
Controller TR-200, FST). An initial incision was made on the medial aspect of the 
hindlimb, directly above the gracilis muscles. This incision was then widened to expose 
most of the medial aspect of the thigh, from the abdominal wall to approximately the 
insertion of the gracilis muscles into the tibia. Phosphate Buffered Saline (PBS) solution 
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was applied to the exposed tissue to prevent desiccation of the skeletal muscles and 
vasculature.. Following the exposure of the medial aspect of the thigh, the fat pad 
perfused by the epigastric artery was blunt dissected posterior to the epigastric branch. 
This fat pad was then bisected at this dissection point using a heat cautery (Bovie, Aaron 
Medical). The two halves of the fat pad along with the abdominal wall were retracted to 
increase exposure of the muscular branch. The obturator nerve, which innervates the 
gracilis muscles, was identified and approximately 1-3mm of its length was dissected 
proximal to its insertion into the gracilis muscles. The positive electrode was then 
inserted into a flap of skin near the knee to function as the ground (Figure 15). With the 
assistance of the #5/45 forceps the negative electrode was then inserted under the 
dissected aspect of the obturator nerve (Figure 16). The use of PBS solution was then 
replaced with mineral oil.  
 
Mineral oil was used for several reasons. First, mineral oil does not permit oxygen 
exchange between the exposed hindlimb and outside air, unlike PBS. This is important, 
because if oxygen is allowed to be exchanged with the environment then it lowers that 
oxygen that the muscles demand from the circulatory system. Thus, arteries such as the 
muscular branch will likely be abnormally constricted because there is less oxygen 
delivery demanded from them. Plastic wrap was also considered, because it could also 
block oxygen exchange with the environment, however it was difficult to keep the wrap 
in place and adjust the SDF intravital microscope such that it was in an optimal position 
to visualize the muscular branch. 
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Figure 15. SDF imaging experimental setup. In the upper picture (A) the microscope used for dissection 
(1) (SMZ800 Zoom Stereo Microscope, Nikon) and SDF video microscope (2, also location of image focus 
and light control) are on either side of the animal to alleviate space issues such that they only need to rotate 
to switch positions. A chemistry stand with vertical fine adjustment (3) and clamp holding oxygen and 
anesthesia delivering tubes (4) aid experimental control. In the bottom picture (B) retractors (9) help to 
expose the muscular branch for visualization by the MicroScan probe (7), the heating pad (8) and rectal 
thermometer (11) maintain thermostasis, while improvisational instruments are used to raise (10) and lower 
(5) the hindlimb to be in the same horizontal plane as the probe. Finally, during stimulation, electrodes are 
used to stimulate gracilis contraction, such that the positive electrode (13) is inserted into a flap of skin and 
the negative electrode (12) is placed under the dissected aspect of the obturator nerve, with a chemistry 
clamp (6) used to adjust its height so it does not put too much tension on the obturator nerve and rip it. 
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Figure 16. Placement of negative electrode. The negative electrode (1) was placed under the dissected 
portion of the obturator nerve (2), so that the SDF video microscope could image the muscular branch 
artery (3) following gracilis muscle (inside rectangular box) contraction. 
 
The SDF intravital video microscope (MicroScan, Microvision Medical), attached to a 
chemistry clamp stand was then moved into an initial position to adequately image the 
muscular branch artery (Figure 15). This position was then finely adjusted while also 
adjusting the hindlimb to position it in the horizontal plane. Regions of the exposed 
muscles where the probe was not present were then covered with plastic wrap to reduce 
runoff of the oil. The hindlimb was then allowed to recover from the dissection and 
associated insults for 30 minutes. Following this thirty-minute rest/recovery period, a 10 
second video using the inravital video microscope was taken. Subsequently, the obturator 
nerve was stimulated to contract the gracilis muscles at 8Hz, 4Hz, or 2Hz, at a 500µs 
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square pulse duration and 1.0mA pulse amplitude for 3 minutes. Immediately after 
stimulation another 10-second video was recorded. Following stimulation the hindlimb 
was allowed to rest for 6 minutes such that the muscular branch artery was allowed to 
regain resting vascular tone.  The stimulation and recovery process was repeated for each 
of the three frequencies. Frequency order was randomized for each mouse. Following all 
stimulations the hindlimb was covered in plastic wrap and the entire surgical and video 
recording procedure was repeated for the contralateral limb. After completion of the 
examination of both limbs, the mouse was euthanized by cervical dislocation. Mice were 
stored at -20°C and disposed of with biohazard waste. 
 
 
2.3. FEMORAL ARTERY LIGATION SURGICAL PROTOCOL 
Surgeries were performed on C57/B6 mice under aseptic conditions and using Isoflurane 
anesthesia (see Appendix D for experimental checklist). The mice were kept at a 
temperature of 35±1.0°C using a rectal-temperature controlled heating pad pad. An initial 
incision was made on the medial aspect of the hindlimb, directly above the femoral 
neurovascular bundle. This incision was extended from just beyond the abdominal wall to 
the beginning of the saphenous artery along the neurovascular bundle. Sterile saline 
solution was used to irrigate the incision and to prevent muscle desiccation. Connective 
tissue was blunt dissected. In addition, the connective tissue underneath the fat pad 
covering the muscular branch was dissected to allow for movement and exposure. 
Following this dissection the fat pad was pushed aside to identify a site for ligation just 
distal to the deep femoral artery branch. At this site the nerve was carefully blunt 
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dissected away from the femoral artery along a length of 1-2mm. The vein was 
meticulously blunt dissected away from the artery to a similar length. The dissected 
femoral artery was then ligated using sterile 6.0 silk suture. Following ligation, the skin 
incision was closed using 7.0 polyprepylene suture.  
 
An equivalent incision was made to the contralateral hindlimb, above the femoral 
neurovascular bundle. Again, sterile saline solution was used to (irrigate) prevent tissue 
desiccation. Connective tissue was blunt dissected. Contact with the neurovascular 
bundle was avoided in order to simulate every aspect of the surgery except the vascular 
insult. Finally, the skin incision was closed up with 7.0 polypropylene suture. The mouse 
was then given a subcutaneous injection of buprenorphine (0.075mg/kg) and allowed to 
recover on a hot pad until ambulatory. Mice were returned to the vivarium at the end of 
the day. 
 
2.4. FEMORAL ARTERY RESECTION SURGICAL PROTOCOL 
Surgeries were performed on C57/B6 mice under aseptic conditions and using Isoflurane 
for anesthesia (see Appendix E for experimental checklist). The mice were kept at a 
temperature of 35±1.0°C using a using a rectal-temperature controlled heating pad. An 
initial incision was made on the medial aspect of the hindlimb, directly above the femoral 
neurovascular bundle. This incision was extended from just beyond the abdominal wall to 
near the ankle of the hindlimb (just below the midway point between the knee and the 
heel) (Figure 12). Sterile saline solution was used to prevent muscle desiccation. 
Connective tissue was blunt dissected. The fat pad covering the muscular junction was 
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then blunt dissected away from both the muscular tissue below and the abdominal wall. 
The epigastric artery was then cauterized and a square of the fat pad was then removed to 
increase exposure of the muscular branch. The nerve within femoral neurovascular 
bundle was then carefully blunt dissected away from the artery vein pair along the entire 
length of the femoral artery. After complete separation of the nerve from the artery vein 
pair, the femoral artery vein pair was dissected from the tissue directly below.  The 
femoral artery-vein pair was then ligated just proximal to the muscular branch with 6.0 
silk suture. The muscular branch artery and vein were dissected at the junction from the 
femoral artery and cauterized. Then the saphenous artery vein pair was ligated at the 
point half way between the knee and the heel. The vessels were then cauterized below the 
ligature and the ligature was used to pull up the vascular pair to the first ligature, while 
cutting and cauterizing vascular branches as necessary. The artery vein pair was cut distal 
to the first ligature. Finally the skin incision was closed with 7.0 polypropylene suture. 
 
The contralateral limb was then treated the same as the sham surgery for the ligated mice. 
The mouse was then taken off of anesthesia, given a subcutaneous injection of 
buprenorphine (0.075mg/kg) and allowed to recover on a hot pad until ambulatory. Mice 
were returned to the vivarium at the end of the day. 
 
 
2.5. VASCULAR FUNCTION EXPERIMENTS ON ISCHEMIC MICE 
Experiments were performed on C57/B6 mice 14 days after each surgery in the same 
manner as the section, Vascular Function Experiments on Mice Not Surgically Altered 
38 
(see Appendix C for experimental checklist), with a few amendments. For example, in 
resected mice, the fat pad of the ischemic limb had already been removed. Thus, minor, 
newly formed adipose only needed to be dissected. Furthermore in these mice, the 
muscular branch was refractory to vascular tone recovery following the cessation of 
stimulation. Thus, a frequency of 8Hz was always executed first as it was the most 
important stimulation frequency, because this large frequency should yield a maximal 
vascular response. Aside from this, stimulation frequency was randomized. Finally, mice 
underwent ventricular catheterization and perfusion fixation following final video 
recordings. 
 
 
2.6. SDF IMAGING ANALYSIS PROTOCOL USING AVA (AUTOMATED VASCULAR 
ANALYSIS) 
The MicroScan was first calibrated according to the manufacturer’s specifications to 
ensure accurate data collection. During data collection, the microscope probe was placed 
such that the planes of the probe and the hindlimb were parallel and that contact between 
the limb and probe was minimized to reduce any effects forceful physical contact may 
have on vascular function. To record a video AVA software version 3.0 was opened, 
calibration settings for the microscan peripheral were loaded and the “capture” option 
was selected (Figure 17). Mouse information was entered and the video duration was set 
at 10 seconds. Following either the 30 minutes of rest or 3 minutes of stimulation ten 
second videos were recorded and saved. 
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Figure 17. AVA capture workspace. Capture workspace, with capture options and current video recording 
[63]. 
 
After video collection AVA was again opened and the “analysis” option was selected 
(Figure 18). Once the analysis workbook appeared one of the videos recorded was 
opened. The video was then stabilized using the automated video stabilization button to 
reduce any movement that may have occurred during recording due to breathing (mouse) 
or any other causes. The muscular branch artery is considered a large vessel by the AVA 
software and large vessels are to be manually traced. Thus the manual tracing tool was 
selected and the muscular branch in each video was carefully traced segment by segment 
down the length of the vessel (vessel length varied due to tissue occasionally obscuring a 
portion of the vessel). Once this segmentation is completed the segments are linked and 
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averaged to give an accurate measurement of the vessel diameter. To improve accuracy 
this process was repeated at 1 (30 frames) and 2 seconds (60 frames), and the three 
diameters were averaged. 
 
 
Figure 18. AVA analysis workspace. The workspace has controls for video stabilization (1), focus 
adjustment (2), manual tracing (3), connecting vessel segments (4), moving between video frames (6), 
opening video files (7). Vessel output is then displayed when each vessel segment is selected (5) (adapted 
from [63]). 
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2.7. STATISTICAL ANALYSIS 
Vasodilation in healthy animals was evaluated by examining muscular branch artery 
diameter changes after gracilis stimulation at various frequencies. Statistical significance 
between each condition in the same mouse was assessed using the Tukey-Kramer test. 
Factors such as mouse ID (i.e. the number that distinguishes each mouse), limb order and 
right/left limb were assessed using balanced ANOVA and a paired means t-test. Vascular 
function and repair after each surgery was evaluated by looking at both arterial diameter 
(analyze any remodeling) and vasodilation (see Equation 1). Percent diameter increase 
was used to demonstrate how much the artery could expand relative to its resting  
 
Equation 1.               
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diameter. Vasodilatory ability and remodeling comparisons between the sham, ligation 
and resection surgeries were analyzed using balanced ANOVA, a paired means t-test 
(limbs on the same mouse and exposed to the same stimulation frequency) and 
differences between each condition (surgery and frequency) were assessed using a t-test 
based on the differences between contralateral limbs. 
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III. RESULTS 
 
 
3.1. FUNCTIONAL HYPEREMIA IN HEALTHY ANIMALS 
In accordance objective 1 (pg. 29), an SDF imaging protocol was established to evaluate 
functional vasodilation in the muscular branch artery.  Stimulation of the obturator nerve 
and contraction of the gracilis muscles resulted in maximal vasodilation at a frequency of 
8Hz (Figure 19). Specifically, gracilis stimulation induced a significant increase in 
arterial diameter from 64.8±1.9!m to 118.4±4.7!m at 8Hz, p<0.001 (n=10). 
Furthermore, each stimulation frequency elicited significantly different levels of 
vasodilation, except between 4Hz and 8Hz, where there was an increase in dilation, but 
not a statistically significant difference. 
 
Further, this maximal vasodilation was statistically significant relative to the resting 
diameter as there was nearly a 100% increase in arterial diameter. The data demonstrates 
a relationship between frequency of muscle stimulation and vascular diameter. 
Interestingly, the order in which the hindlimbs were evaluated was statistically significant 
to the corresponding levels of vasodilation (percentage increase) (Figure 20). The 
hindlimb examined first demonstrated enhanced vasodilation compared to that imaged 
later (78% compared to 56% increase, p=0.006). This was important for future 
experiments as limb order continued to be randomized. 
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Figure 19. Vasodilation in healthy mice. A bar graph of the mean muscular branch artery luminal diameter 
following gracilis stimulation at 1mA, 500µs and 2Hz, 4Hz or 8Hz for 3min (A) (*p<0.001). A chart 
showing the quantiles and distribution of arterial diameters at each condition and a Tukey-Kramer diagram 
showing significant differences (p<0.05) where the circles do not overlap (B). Single frames taken by the 
MicroScan of the muscular branch artery during rest (C) and following stimulation of the gracilis muscle at 
a frequency of 8Hz (D). 
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Figure 20. The importance of limb order. A distribution of vasodilation levels in the first and the second 
hindlimb imaged, which connects data points between limbs on the same mouse and vasodilation levels at 
the same frequency (A), showing that in most experiments vasodilation levels decreased between the first 
and second limb imaged. A depiction of a paired t-test done for vasodilation levels in the first vs. second 
limb imaged at a certain frequency (B). The horizontal dotted red lines show the 95% interval for the 
difference between the first and second limb, demonstrating that the higher levels of vasodilation in the first 
limb imaged was statistically significant (p<0.05). 
 
 
3.2. OUTWARD REMODELING AND VASODILATION FOLLOWING ARTERIOGENIC ISCHEMIA 
As expected, the muscular branch artery luminal diameter was larger in the ligated 
hindlimb or the hindlimb that underwent femoral artery ligation. The resting diameters of 
ligated hindlimbs were 72.0±3.6!m compared to 61.3±2.1!m in the non-ischemic 
contralateral limbs (Figure 21). In addition, the arterial diameters following gracilis 
stimulation at 8Hz were 120.0±4.8!m and 105.9±1.3!m in ligated and non-ischemic 
limbs respectively.  
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Figure 21. Arteriogenesis of the muscular branch artery in ligated mice. A bar graph comparing the 
muscular branch artery diameter in the ligated ischemic and non-ischemic hindlimb at rest and following 
stimulation at 1mA, 500µs and 8Hz for 3min (n=6) (A). These observations were recorded on day 14 
following ligation and sham surgeries on contralateral limbs of C57/B6 mice. Charts showing the 
distribution of arterial diameter values following sham and ligation surgeries at various frequencies (B) 
demonstrate that the muscular arterial diameter following the ligation surgery is significantly larger than 
that of the sham surgery at rest and at maximal dilation (also see Figure 23 for examples of the videos this 
data was based on). 
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Vascular function was assessed, in the muscular branch of the ligated mice and compared 
to the same vasculature in the non-ischemic hindlimb. There was no significant 
difference in vascular function of the remodeled muscular branch artery when compared 
to the non-repaired muscular branch (Figure 22). 
 
 
Figure 22. Vasodilation of the 
muscular branch artery in ligated 
mice. A bar graph showing 
muscular branch artery diameter 
increase (% increase) at 1mA, 
500µs and 2Hz, 4Hz or 8Hz for 
3min, in limbs sustaining either 
a sham or femoral artery ligation 
surgery (A). Also shown, a chart 
of the distribution of arterial 
vasodilation in paired limbs (i.e. 
same mouse, same stimulation, 
one ligated and one sham), 
which shows no significant 
change in vasodilation between 
limbs receiving a sham surgery 
and those receiving a ligation 
surgery (dotted red lines indicate 95% CI). This data was evaluated on day 14 following surgery on both 
the ligated and non-ischemic hindlimbs (also see Figure 23 for examples of the videos this data was based 
on). 
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Figure 23. Images of muscular branch artery changes in ligated mice. Samples freeze frames from videos 
recorded of the muscular branch artery of a non-ischemic hindlimb at rest (A) and following a gracilis 
stimulation of 8Hz (B), in addition to freeze frames from videos recorded of the muscular branch artery of 
the ligated contralateral hindlimb at rest (C) and following a gracilis stimulation of 8Hz (D). 
 
 
 
3.3. ARTERIAL RESTING TONE AND VASODILATION FOLLOWING NON-ARTERIOGENIC 
ISCHEMIA 
In contrast, in those mice that experienced femoral artery resection, the muscular branch 
arterial diameter was not statistically different from the diameter of the equivalent artery 
on the contralateral non-ischemic limb (Figure 24). 
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Figure 24. Neutral remodeling of the muscular branch artery in resected mice. Muscular branch artery 
luminal diameters in the resected ischemic and non-ischemic hindlimb at rest and following stimulation at 
1mA, 500µs and 2Hz, 4Hz or 8Hz for 3min (n=4) (A). At each condition there is not a significant 
difference in diameter. Also shown, a chart of the distribution of arterial diameters in paired limbs (i.e. 
same mouse, same stimulation, one resected and one sham), which shows no significant change in arterial 
diameters between limbs receiving a sham surgery and those receiving a resection surgery (dotted red lines 
indicate 95% CI). This data was evaluated on day 14 following surgery on both the resected and non-
ischemic hindlimbs (also see Figure 26 for examples of the videos this data was based on). 
 
49 
Vascular function was also analyzed in the muscular branch artery of resected mice and 
compared to that in the non-ischemic contralateral limb. There appeared to be no 
significant trend indicating a change in vascular function in the repaired resected 
hindlimb compared to the non-ischemic hindlimb (Figure 25). However, during the 
experiments it was clear that the muscular branch artery in the resected hindlimb was 
refractory to regaining resting vascular tone following the cessation of stimulation. 
Normally, a wait of 25-30 minutes, if not longer, was needed for the muscular branch 
arterial diameter to return close to its resting diameter. This is a significant increase in 
time when compared to the 4-8 minutes that were required for the muscular branch artery 
to constrict in both the ligated and non-ischemic hindlimbs. Unfortunately, this 
observation was only observed qualitatively during experiments and thus there are not 
any data on a potential impairment of vascular function, specifically concerning the 
recovery of resting vascular tone. This may be an observation that deserves further 
examination. 
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Figure 25. Vasodilation of the muscular branch artery in resected mice. Muscular branch artery diameter 
increase (percentage increase relative to resting diameter) at 1mA, 500µs and 2Hz, 4Hz or 8Hz for 3min, in 
limbs sustaining either a sham or femoral artery resection surgery (A). Also shown, a chart of the 
distribution of arterial vasodilation in paired limbs (i.e. same mouse, same stimulation, one resected and 
one sham), which shows no significant change in vasodilation between limbs receiving a sham surgery and 
those receiving a resection surgery (dotted red lines indicate 95% CI). This data was evaluated on day 14 
following surgery on both the resected and non-ischemic hindlimbs (also see Figure 26 for examples of the 
videos this data was based on). 
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Figure 26. Images of muscular branch artery changes in resected mice. Samples freeze frames from videos 
recorded of the muscular branch artery of a non-ischemic hindlimb at rest (A) and following a gracilis 
stimulation of 8Hz (B), in addition to freeze frames from videos recorded of the muscular branch artery of 
the resected contralateral hindlimb at rest (C) and following a gracilis stimulation of 8Hz (D). 
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IV. DISCUSSION 
 
 
4.1. RESTATEMENT OF EXPERIMENTAL OBJECTIVES 
To guide the discussion of experimental results, recall the primary goals: 
1. Establish a consistent protocol for the SDF imaging intravital microscope to 
examine muscular branch arterial changes during functional hyperemia induced 
by gracilis stimulation. 
2. Examine (using the established SDF imaging protocol) collateralization of the 
muscular branch artery two weeks after ischemic surgeries.  
3. Examine vascular functional hyperemia following arteriogenic and non-
arteriogenic ischemic insult.  
 
 
4.2. VASODILATORY RESPONSE IN HEALTHY MICE 
An SDF imaging protocol was established to consistently evaluate the hindlimb 
vasculature (and will be discussed). Functional vasodilation in the muscular branch artery 
as a result of gracilis muscle contraction was examined following stimulation of the 
obturator nerve. As expected, isometric gracilis muscle contraction induced an increase in 
the diameter of the muscular branch artery, so to augment blood flow and satiate 
metabolic demands. Furthermore, there was a stepwise enhancement of the vasodilatory 
response when the stimulation frequency was increased from 2Hz to 4Hz to 8Hz. A 
similar response was observed in previous examinations of the rat spinotrapezius muscle 
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(as well as other muscles), where an increasing electrical stimulation frequency elicited 
progressively elevated distension of vasculature diameter in the aforementioned muscle 
[64]. This reaction observed both in the gracilis and spinotrapezius muscles of the mouse 
and rat, respectively, is practically relevant to muscle and circulatory function during 
exercise; in these experiments increasing the frequency of muscle contractions was 
analogous to escalating the intensity of exercise in vivo. In this way, amplification of 
muscle activity results in elevated metabolic demand as muscles both consume and 
require more nutrients. To quench this demand, perfusing arteries dilate in order to 
increase nutrients and oxygen supplied to contracting skeletal muscle via blood flow 
augmentation. The evaluation of vasodilatory function in the muscular branch artery was 
necessary to ensure that the established dissection, stimulation and imaging protocol was 
capable of acquiring consistent results and observing the expected arterial response like 
that observed in the rat spinotrapezius [64].  
 
4.3. SDF IMAGING PROTOCOL MODIFICATIONS 
Following some protocol revisions, the SDF imaging microscope was capable of 
consistently observing and recording arterial diameter changes in the muscular branch 
artery. Initially, vasodilation data acquired yielded high variability and error, thus a 
number of key modifications were needed to address these problems (Figure 27). The 
most important procedural consideration was to increase the allowed recovery time 
following tissue dissection and prior to muscle stimulation and SDF video imaging from 
15 to 30 minutes. This time was imperative to allow for the recovery of vascular tone 
following dissection and exposure. If this time was not allotted a number of problems 
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occurred. The resting diameter of the muscular branch artery was not always reached, as 
the artery did not fully regain resting vascular tone. In addition, there were instances 
when the artery was refractory to the stimulus of muscle contraction and would not 
vasodilate to meet the metabolic demands of the gracilis muscles. Specifically, referring 
to instances involving the muscular branch of non-ischemic and resected hindlimbs, the 
muscular branch artery only dilated from 71.94µm (resting) to 90.11µm (8Hz) and 
76.160µm (resting) to 87.09µm (8Hz), respectively. This level of dilation was especially 
low when compared to other observed results. Furthermore, these instances did not 
appear to occur during conditions when the force of gracilis contraction were was 
seemingly depressed. These instances of abnormal vasodilation combined with the more 
common inability for the muscular branch to regain resting diameter following dissection 
led to inconsistent and inconclusive results.  
 
While extending the recovery time prior to nerve stimulation from 15 minutes to 30 
minutes ameliorated these negative results, the protocol also needed to be adapted to 
address the difficulties involved with placing this large (relative to hindlimb) SDF probe 
such that the horizontal imaging plane was parallel to the hindlimb surface in order to 
reduce contact with the muscular branch artery. Given the aforementioned large size of 
the probe and the modest flexibility of the abdominal wall, it was slightly problematic to 
position the microscope in the correct location for muscular branch artery visualization 
without the probe placing pressure on the hindlimb. To remedy this problem, special 
attention was placed to probe positioning and the hindlimb was leveled in the horizontal 
plane as much as possible using a combination of cotton swabs, tongue depressors and 
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metal spatulas. This was approached with two objectives in mind: to ensure that the probe 
would not contact the muscular branch artery or other hindlimb microcirculation and that 
the probe would not interfere 
 
 
Figure 27. Inconsistent data from original imaging protocol. (A) Muscular branch artery vasodilation 
measurements prior to protocol modifications (Protocol 1) and after protocol modifications (Protocol 2). 
The standard error during most conditions was reduced by at least half of the previous error when the new 
protocol was utilized. (B) A table of a collection of data collected when using the initial protocol. 
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with gracilis muscle contractions. While this was effective, methods were considerably 
improvisational. Thus, creating a more uniform method to address these concerns would 
be in the interest of future experiments with the SDF intravital microscope. Specifically a 
microscope stand made for the SDF microscope would be especially useful as a 
replacement for the chemistry clamp stand that only had fine adjustment capability in the 
z-direction. A stand would better secure the microscope and allow for improved fine 
adjustments when trying to navigate the hindlimb without interfering with the tissues and 
vasculature.  
 
4.3.1. Potential Protocol Adaptations yet to be Addressed 
There were other inconsistent aspects of the protocol that were identified and considered 
but have yet to be addressed. First, while the induction of gracilis muscle contractions 
through stimulation of the obturator nerve improved contraction strength consistency 
compared to simply piercing the muscle groups and stimulating them directly, muscle 
contraction strength variation was still observed. It was clear during the experiment that 
the same stimuli would at times induce stronger muscle contractions where the entire 
hindlimb would move and at other times induce weaker gracilis muscle contractions 
generally only visible through the microscope. For example in one healthy control mouse 
the arterial diameter was 112.6!m in the left hindlimb and 90.7!m in the right hindlimb 
following the same stimulus of 2Hz. In another healthy control mouse the muscular 
branch arterial diameter was 122.7!m in the left limb and 90.7!m in the right limb at a 
frequency of 4Hz. Often, it appeared as though the limb containing the muscular branch 
artery that dilated more experienced more forceful gracilis contractions.  
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This data was likely not caused by which limb was being imaged, because the limb being 
imaged (left or right) did not have a significant influence on vasodilation (P=0.432) (this 
is distinct from the order limbs were imaged: first or second). When the stimulation 
frequency was at 8Hz this variation in vasodilation was observed with a lesser degree of 
incidence. This is thought to be, because at a frequency of 8Hz it was likely that the 
stimulus was inducing the maximal dilatory response from the vessel. Previous research 
demonstrated that arterioles in the hamster cremaster muscle exhibited maximal dilation 
in response to electrical stimulus at 8Hz [65]. Based on Figure 28 taken from the 
aforementioned hamster study, slight inconsistencies in the applied stimuli during low 
frequency and long-term stimulation would result in more significant diameter changes 
compared with variations induced by inconsistencies during higher frequency 
stimulation. In terms of the protocol, changes in the effective stimulation elicited by the 
electrode may have been due to variation in electrode placement, specifically, contact 
with the obturator nerve may have influenced the ability for the same frequency and 
amplitude to excite the nerve to the same degree. Additionally, it is unclear to what 
degree the obturator nerve was damaged upon dissection and any variation in the amount 
of tissue damage may have also led to inconsistencies. Again, based on Figure 28, these 
inconsistencies would likely be less obvious at 8Hz when a maximal vasodilatory 
response is elicited.  
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Figure 28. Arteriole vasodilation in the cremaster. The late peak occurred on average after 100 seconds of 
stimulation and thus is most analogous to the mouse hindlimb observations where the gracilis was 
stimulated for 180 seconds [65]. 
 
Muscle fatigue also appeared to affect the magnitude of these contractions. Even when 
the contractions were large at the beginning of stimulation and analysis as the experiment 
progressed there appeared to be a marked decrease in the strength of the muscle 
contractions. This fatigue was also apparent when evaluating vascular function. At times 
a weaker stimulation frequency induced a larger change in arterial diameter than a higher 
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stimulation frequency if the weaker frequency was executed first. For example, in one 
normal mouse the muscular branch arterial diameter was 109.5!m following a 
stimulation frequency of 4Hz compared to 100.0!m following a stimulation frequency of 
8Hz when the 4Hz stimulation was completed first.  
 
4.3.2. Future Protocol Improving Modifications 
To remedy these inconsistencies in muscle stimulation and resultant arterial vasodilation 
a number of these matters can be addressed. A parallel bipolar electrode with a curved tip 
to hook the obturator nerve, instead of a straight microelectrode would help to make 
nerve stimulation and the resultant muscle contraction more consistent. Specifically the 
hooked aspect of the electrode would limit any movement caused by the placement of the 
intravital microscope, as the probe and the electrode essentially need to occupy the same 
space in the hindlimb. With consideration of this problematic spacing, it may be useful to 
test the hypothesis that stimulation of the activating nerve induces more consistent 
muscle contractions than does direct stimulation of the muscle group. Should this 
hypothesis not be supported, suggesting that there is no benefit to direct nerve 
stimulation, then directly stimulating the muscle would alleviate some spacing issues as 
the electrodes could be placed at a position along the muscle farther from the muscular 
branch and the SDF intravital microscope.  
 
To address other inconsistencies in the induced muscle contraction due to fatigue, it may 
be advantageous to consider the following options: only evaluate the microcirculation 
following stimulation at one frequency or increase the time allowed for recovery (6min), 
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while decreasing the stimulation duration (3min). Based on subjective observation during 
experiments, the 3-minute stimulation time was unnecessary, as the muscular branch 
artery often reached its maximal diameter between 45 and 90 seconds. Thus reducing the 
3-minute stimulation duration could ameliorate muscle fatigue.  
 
4.3.3. The Importance of Limb Order and Potential Considerations  
A final significant observation was that the order in which the limbs were imaged (first or 
second) had a significant effect on the vasodilatory response. The limb that was imaged 
first had a 78% increase in diameter compared to limbs imaged second, which had a 56% 
increase in diameter (p=0.006) (Figure 20). This was addressed during subsequent 
experiments by continuing to vary the order in which the ischemic and non-ischemic 
limbs were evaluated. However, this is not the optimal method for addressing this 
variance. It is assumed that this decrease in vascular function was due to low arterial 
pressure, which likely decreased during the experiment as a result of blood volume loss. 
The oxygen gas used in combination with the inhalant anesthetic is very dry. Therefore, it 
is presumed that the animal likely lost blood volume due to excessive evaporation of 
extracellular water, subsequently inducing a decrease in arterial blood pressure and thus 
reduced hydrodynamic force to cause arterial distension. Previous studies have 
demonstrated that anesthesia induces a decrease in heart rate, blood pressure and tissue 
oxygen [66]. This issue has been addressed in other experiments involving prolonged 
anesthesia use, by carotid catheterization to monitor arterial blood pressure and address 
any significant changes [5]. 
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With these considerations and variables withstanding, the protocol for evaluating 
vascular function using SDF imaging was suitable for subsequent experiments. Still, 
potential improvements can be made. 
 
 
4.4. FLOW CONTROL/ARTERIAL VASODILATION DURING REMODELING OF THE MUSCULAR 
BRANCH ARTERY 
Following verification of experimental protocols, the objective (as previously stated) was 
to examine vascular function following differing conditions of ischemia and remodeling. 
Thus, remodeling and then the collateral artery vasoactivity was evaluated with and 
without arteriogenesis (ligation and resection models respectively).  
 
4.4.1. Arteriogenesis 
As expected, the hindlimb ischemia caused by ligation of the femoral artery induced 
arteriogenesis of the muscular branch artery. Specifically, this collateralization was 
induced by the enhanced shear stress caused by the divergence of blood flow away from 
the superficial femoral artery and into the muscular branch and deep femoral arteries. 
This result is in support of previous research, which has demonstrated that in the same 
ligation model, collaterals in the gracilis muscle increased in diameter by 60% after 3 
weeks [55]. In this experiment the muscular branch artery in the ischemic hindlimb was 
17.4% larger than the same artery in the non-ischemic contralateral limb at rest after 2 
weeks (p=0.006). Further, the muscular branch artery in the ischemic hindlimb was 
13.3% larger than the same artery in the non-ischemic contralateral limb following 8Hz 
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stimulation. It is expected that given another week for revascularization the artery may 
have expanded more, thought it would likely not experience the 60% increase in diameter 
observed in previous studies. However, the cited research that observed a 60% increase, 
examined smaller vessels within the gracilis compared to the large muscular branch 
arteriole, which likely normalized its response to elevated shear stress with a smaller 
percent increase in diameter [55].  
 
4.4.2. Vasodilation in Arteriogenic Conditions (Femoral Artery Ligation) 
Based on the aforementioned data it appears (based on previous research) that 
collateralization of the muscular branch was induced by the femoral artery ligation 
conditions (primarily high shear stress, normoxia and likely mild inflammation) [32]. 
Additionally it was expected that in this model, the conditions of high shear stress, would 
cause endothelial dysfunction and a loss of vasodilatory ability. While there appeared to 
be a trend towards impaired vascular function in the muscular branch artery, no 
significant (p>0.05) vasodilatory dysfunction was observed. This result was in contrast to 
what was hypothesized and previous research that demonstrated that hindlimb ischemia 
induced vascular dysfunction [5, 17]. This previous research used a rat hindlimb ischemia 
model involving ligation of the common iliac artery; it was demonstrated that in the 
tibialis anterior (TA), 2 weeks after ligation, mild stimulation induced slight 
vasoconstriction in the muscle perfusing arterioles [5, 17]. Further research demonstrated 
that in the extensor digitorum longus (EDL) arterioles constricted when exposed to 
acetylcholine (ACh), normally an agent that induces endothelial dependent vasodilation 
[5]. Another endothelial-dependent vasodilator, bradykinin, was also shown to have an 
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impaired effect on the same vasculature following ligation [5]. Additionally it was 
demonstrated that endothelial-independent vasodilators also had an impaired effect on 
vascular function, but not until week 5 [5]. This seems to indicate that under ischemic 
conditions (following iliac artery ligation) in the lower limb endothelial regulation of 
vascular function is severely damaged as early as 2 weeks after ligation [5]. Other studies 
have confirmed the importance of endothelial integrity to vasoactivity, by damaging 
(through denudation) the inimal (EC) layer in the pig iliac artery and observing a 
constrictive response to ACh exposure (noramally a vasodilator) [67]. While it was 
hypothesized that similar vascular function impairment would occur in the collateral 
arteries of the thigh following femoral artery ligation (when elevated shear stress would 
cause endothelial deformation), this was not the case. Thus it is imperative to understand 
the differences in the tissue and blood flow conditions between the femoral artery ligation 
model, which this experiment used and the iliac ligation model that earlier experiments 
utilized. 
 
4.4.3. A Comparison of Hindlimb Ischemia Models to Clarify Vasodilation Results 
The most fundamental difference between these studies, but likely the most difficult to 
account for, was that the iliac ligation model was used in a rat and the femoral ligation 
model was used in a mouse. Thus, when considering differing results it is important to 
understand that even though both models were used in rodents, experimental conclusions 
may not always translate (similarly breakthroughs in animal disease models may not 
always work for humans or successful therapies may only help a subset of patients). With 
that in mind there are a number of other significant distinctions between each model. In 
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the iliac artery ligation model resting blood flow to the entire hindlimb was reduced [5]. 
Specifically in the TA and EDL muscles, blood flow decreased by 40% [5]. These 
muscles also experienced significant hypoxia as a result of the insufficient blood flow [5, 
17]. Gradual collateralization only induced a mild increase in blood flow by week 5 [5]. 
Thus, in the iliac artery ligation model it appeared that outward remodeling was an 
unlikely cause for the impairment of endothelial-dependent vascular control that occurred 
by week 2 [5, 17].  
 
An important distinction between the vasculature studied by two models should be made, 
in that the muscular branch is a large arteriole, while the vessels examined in the previous 
models were smaller. Given that, it seems that the causes of endothelial-dependent 
vascular dysfunction in small, muscle perfusing vessels was not due to high blood flow, 
but instead factors that may include significant hypoxia and inflammation.  
 
In the femoral artery ligation, however, it is expected that blood flow through the 
muscular branch artery is relatively undiminished. In fact, there should be an increase in 
blood flow and shear stress through the muscular branch artery as blood is diverged away 
from the occluded femoral artery. Blood perfusion through the ventral adductor muscle of 
the ischemic limb was approximately 1.3 and 1.5 times higher than the non-ischemic 
limb on days 3 and 7 respectively [55]. In the gracilis muscle, collateral diameter had 
increased 60% by week 3 [55]. Thus, collateralization was not gradual in the upper limb 
of the femoral artery ligation model as it was in the lower limb in the iliac artery ligation 
model.  Further, hypoxia in the upper limb of the femoral artery ligation model was less 
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severe than in the lower limb of the iliac ligation model or even the lower limb of the 
same model [5, 17, 42].  
 
Thus, based on the iliac artery ligation model hypoxia and low blood flow appear to be 
more likely causes for endothelial cell dysfunction compared to collateralization and high 
shear stress; therefore, the lack of vascular impairment that was observed in the femoral 
artery ligation model may have been expected. However, it is difficult to extend this 
conclusion necessarily to the larger arterioles examined in this mouse model. There are so 
many distinctions between these models that deducing the reason for the lack of vascular 
impairment requires more research. It could be that shear stress does not induce vascular 
dysfunction as speculated. However, it is possible that shear stress may induce 
dysfunction in smaller vessels like those evaluated in the iliac model rather than a vessel 
as large as the muscular branch. Perhaps low blood flow and its associated insults 
(hypoxia, nutrient shortage) are the primary cause for dysfunction and that is why in the 
femoral ligation model, where blood flow was high, impairment was not observed.  
 
Inflammation severity may also play a role in dysfunction, and if so inflammation is 
expected to be higher in the lower leg where observations following iliac artery ligation 
were made. Further investigations will be required to continue to sort out the potential 
physiological causes for vascular dysfunction, but the observations of vascular 
remodeling and function following femoral artery resection may help further elucidate 
these factors. 
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4.4.4. Remodeling Following Non-Arteriogenic Ischemia 
In contrast to the femoral artery ligation model, the muscular branch artery in resected 
mice experienced minimal increases in shear stress and did not significantly outwardly 
remodel. Instead, there was neutral remodeling that occurred in this artery (Figure 24). 
The average resting diameter of the muscular branch artery was 63.3!m in the non-
ischemic contralateral hindlimb and 53.2!m in the ischemic hindlimb (p>0.05). The 
average diameter for the muscular branch artery following 8Hz stimulation was 113.1µm 
in the non-ischemic contralateral hindlimb and 105.3!m in the ischemic hindlimb 
(p>0.05). Thus there appeared to be a slight but not significant decrease in the luminal 
diameter of the muscular branch following femoral artery resection and subsequent 
revascularization after 2 weeks. Previous studies have stressed the importance of shear 
stress in the induction of outward remodeling [30, 32, 33]. This would imply that since 
there was neutral arterial remodeling that there was no increase in shear stress or blood 
flow following the ischemic insult. Based on observation, using the intravital microscope, 
blood flow through the muscular branch artery appeared particularly low/turbulent 
(qualitatively) (Figure 29). As stated previously, SDF imaging measures blood flow 
based on the contrast between dark hemoglobin containing red blood cells and white non-
hemoglobin containing blood and tissue constituents. It was not possible to measure the 
blood flow through the muscular branch artery for two reasons: it was too large 
(diameter) and blood flow was too high. Thus, the contrast between black and white (red 
blood cells and plasma/white blood cells respectively) was not discernable. However, in 
some of the video samples taken with the SDF microscope of resected mice, contrast was 
distinguishable (Figure 28). Moreover, based on observation the contrast appeared to be 
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swirling around and seemed to indicate that blood flow here was significantly lower and 
possibly turbulent. Previous research and the observation that this turbulent flow was 
predominantly directed from the gracilis to the superficial femoral artery (although it did 
appear to shift at times) indicate that blood flow to the gracilis vasculature and muscular 
branch artery, post resection, is being supplied by arteries such the medial circumflex, 
which connect with the muscular branch vasculature below the section of artery that was 
 
Figure 29. Image of turbulent flow in the muscular branch artery of resected mice. An SDF imaging 
snapshot of turbulent and low flow in the muscular branch artery. In the video it also appears that at times 
blood flow is moving up toward the cauterization site and thus not flowing to the gracilis muscle. Although 
during other time segments it seems as though blood flow may shift in the other direction. 
 
imaged [58]. Thus, the low and turbulent flow occured likely because blood was having 
difficulty traveling past the muscular branch artery’s now stump-like end with only small 
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downstream vessels and high resistance (Figure 30). Both steep increases in resistance 
and obstructions (cauterized end of the larger muscular branch artery) are known to cause 
turbulent flow [68]. Interestingly, observations of the gracilis muscles in the hindlimb 
indicated that collateralization did occur throughout the vasculature of the muscle (Figure 
31). This observation is consistent with previous data from a group that examined gracilis 
vasculature using the same model for hindlimb ischemia and found that the 
microcirculation of the ischemic gracilis muscles increased in diameter almost by a factor 
of 1.5 compared to the non-ischemic limb [18]. Thus, based on observation and previous 
data it appears that the impairment of vascular tone and potential decrease in shear stress 
may be exclusive to the muscular branch artery due to its abrupt increase in resistance 
following separation from the femoral artery blood supply during resection.  
 
 
Figure 30. Blood flow changes following femoral artery resection. This diagram indicates how blood flow 
in the muscular branch artery becomes turbulent following femoral artery resection. Both the cauterized 
end of the muscular branch and the high resistance of small arteries connected to the muscular branch 
(recall that resistance is inversely related to the radius to the power of four) promote turbulent flow. 
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4.4.5. Vasodilation Following Non-Arteriogenic Ischemia 
Vasodilation in the muscular branch artery was slightly but not significantly enhanced in 
the resected ischemic compared to the non-ischemic hindlimb (P>0.05). In the resection 
model, no outward remodeling of the muscular branch artery occurred and the resting 
luminal diameter was slightly but not significantly smaller, as previously mentioned. 
Furthermore, the vessel was able to vasodilate to a luminal diameter not significantly 
 
Figure 31. Remodeling of gracilis-perfusing vessels following femoral artery resection. Unfortunately no 
pictures happened to be taken of the contralateral non-ischemic hindlimb. However, based on observation 
these collaterals are significantly larger. 
 
different than the non-ischemic artery. Thus it implies that the smaller resting diameter in 
the resection model yielded a slightly, but not significantly larger capacity for 
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vasodilation; in the non-ischemic contralateral himdlimb the muscular branch artery 
dilated 79.3% following a stimulus frequency of 8Hz, while in the resected limb the same 
artery dilated 103.9% in response to an equivalent stimulation frequency (p>0.05). While 
vasodilation was not impaired, it was clear through observation that the muscular branch 
artery in the resected limb had impaired ability to restore resting vascular tone. Following 
gracilis muscle contraction, the muscular branch artery required an excess of 30 minutes 
to even come close to the resting diameter. This was significantly larger when compared 
to the 5 minutes that were usually required for the same artery in sham and ligated mice 
to restore vascular tone. In a related but not identical response, an impairment of 
vasoconstriction was observed in the hindlimb of iliac artery ligated mice [5]. Following 
superfusion of noradrenaline and 5 weeks after iliac artery ligation arterioles in the EDL 
were not able to vasoconstrict effectively [5]. While the restoration response in the 
resection model is different, these observations do suggest that the tissue environment 
following resection may induce a related loss of vascular function. This is interesting in 
that our hypothesis that endothelial-deforming arteriogenesis would induce vascular 
dysfunction was unsupported, while non-arteriogenic factors such as inflammation and 
hypoxia may have induced blood flow control impairment similar to observations in the 
iliac artery ligation model. It is difficult to quantify this dysfunction, because no data was 
collected for the restoration of resting vascular tone. However, this is a potential area for 
future research of a unique aspect of vascular function. 
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4.5. MODIFICATIONS FOR SUBSEQUENT NON-ARTERIOGENIC ISCHEMIA MODELS 
While this femoral artery resection model did generate some useful data, the observations 
of turbulent and low blood flow in the muscular branch artery demonstrate that blood 
flow through the muscular branch artery is not representative of blood flow through the 
gracilis vasculature (Figure 29, 30). Given this and some of the previously mentioned 
issues associated with analyzing the muscular branch artery following femoral artery 
resection, it would be potentially useful to identify new ways to analyze vascular function 
in vessels that do not undergo arteriogenesis following arterial occlusion with redirected 
blood flow after occlusion. One method would be to avoid the turbulence problems 
associated with the cauterization of the muscular branch artery and image the smaller 
vasculature that perfuses the gracilis muscle. Unfortunately, in the past, imaging these 
vessels using the SDF intravital microscope has proven difficult. Another potential option 
to better evaluate non-arteriogenic ischemia, given that it has been difficult to image 
gracilis vasculature, may be to use a different model or a slightly modified version of the 
resection model of hindlimb ischemia. One option would be to use the previously 
discussed model used to demonstrate impaired vascular function following chronic 
ischemia in the lower limb (EDL). This rat model involved the ligation of the common 
iliac artery, which significantly reduced blood flow in the hindlimb, as the common iliac 
artery serves as the main feed vessel for the hindlimb (recall circulation from Figure 8) 
[69, 70]. In this model the muscular branch artery would be exposed to non-arteriogenic 
conditions, as the vessel does not experience increased blood flow following common 
iliac artery ligation. Importantly, blood flow through the muscular branch would not be 
abruptly occluded (no cauterization required) and velocity through that vessel would be 
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consistent with the vasculature in the gracilis muscle. Thus, SDF imaging could be used 
to evaluate the only artery in the ischemic hindlimb that has been successfully visualized 
and examined. Another potential model, which appears to not have been used as of yet, 
would actually be a modification of the current resection model of hindlimb ischemia. 
This model would involve the resection of the femoral artery vein pair from near the 
saphenous bifurcation to just distally of the deep femoral artery (Figure 32). Then the 
femoral artery vein pair would be ligated proximal to the muscular branch artery (Figure 
32). This model would be nearly identical to the current resection model, except blood 
would be able to flow from the muscular branch artery to the deep femoral artery. Thus, 
there would be no abrupt resistance increase to the muscular branch artery and 
theoretically blood flow would be more representative of that through the vasculature of 
the ischemic hindlimb and specifically the gracilis muscles. 
 
These models could also be used to examine what factors, other than shear stress, induce 
arteriogenesis. Previous research has demonstrated that enhanced shear stress is the 
driving factor for arteriogenesis [32]. However, as stated above, in this low shear stress  
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Figure 32. A modified femoral artery resection model. This surgery would allow for blood flow to flow 
through the muscular branch artery without high resistance following occlusion, yet still keep the vessel 
“out of series” with the diverged blood flow. 
 
resection model, significant collateralization was still observed throughout the gracilis 
(Figure 31). Even more, this outward remodeling often seemed more ubiquitous and 
extensive than in the ligation model of ischemia (no pictures taken, only subjectively 
observed). Understanding what conditions led to this significant collateralization would 
be useful to understanding revascularization. 
 
 
4.6. FUTURE INVESTIGATION 
It remains unclear what specific conditions or processes impair vascular function in 
chronic ischemia. Based on this investigation and previous work it appears that 
collateralization and increased shear stress do not effectuate vascular function impairment 
in arterioles. However, to definitively make this conclusion and identify the cause of 
vascular dysfunction following chronic ischemia, it would be useful to examine 
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conditions of increased shear stress in different arterial types. Furthermore, it would be of 
interest to get a more direct measure of arterial blood flow, either by developing a 
protocol to observe smaller vasculature where SDF imaging is capable of measuring 
blood flow or by taking blood pressure measurements (combining these with luminal 
diameter measurements). It may also be useful to use the proposed modified resection 
model when examining the muscular branch artery, so that the resistance to flow in this 
artery is not abnormally high. A revised resection model to ensure accurate evaluation of 
the muscular branch artery may result in different and interesting results. Finally, it may 
be useful to examine vascular function in the lower hindlimb, where ischemia, hypoxia 
and inflammation are more severe, in order to compare this with data acquired in the 
upper hindlimb. This comparison would carry more validity than that made between the 
ligation model and the iliac model previously discussed because the same model would 
be used in the same species (rather than rat vs. mouse). Ultimately, the identification of 
which factors (shear stress, hypoxia, inflammation, etc.) cause vascular dysfunction 
would be useful for application in PAD. Patients who experience intermittent 
claudication and have difficulty exercising, even if they have gone through successful 
revascularization (surgical or therapeutic) would greatly benefit from therapies 
addressing impaired blood flow control, so that they can exercise and work to reverse the 
progression of this disease. 
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APPENDIX A 
 
 
VASCULAR FUNCTION AND BLOOD FLOW EQUATIONS 
The relation between arterial diameter and blood flow can be described using an 
extension of Ohm’s Law for circuits which describes the relationship between electrical 
current (I), applied electromotive force (E) and resistance (R), and is analogous to the 
relationship between blood flow (F), blood pressure (P) and vessel resistance (Equation 
1a and 1b respectively). Blood vessel resistance can be related to fluid viscosity (!), 
vessel length (L) and vessel radius (r, Equation 1c). Combining these equations (with the 
knowledge that vessel pressure equals the pressure difference between vessel endpoints, 
PA – PB) yields the Poisseuille-Hagen formula (Equation 2). 
 
 
 
 
Equation 2. a) Ohm’s Law for an electrical circuit. b) Ohm’s Law as it applies to blood flow. c) The 
equation describing blood flow resistance (adapted from [12]). 
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Equation 3. The Poisseuille-Hagen formula, a combination  
of the formulas from Equation 1 (adapted from [12]). 
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APPENDIX B 
 
HUSBANDRY PRACTICES 
Daily 
1. Prior to entering room, apply booties & disinfect booties with Clidox.  If changing 
cages, apply bonnet, isolation mask, and isolation gown.  
2. Record room temperature 
3. Check cleanliness of water, which should not be cloudy or opaque 
4. Ensure adequate levels of feed & water 
5. Perform cage census 
6. Observe behavior within cage 
a. On cage activity form, record unusual injury*, illness**, and fighting 
b. If animals are found dead or moribund (near death), contact Trevor 
Cardinal (6-6244, 503-9837) 
7. Record notes and activities in notebook 
  
Weekly (or more frequently if needed***) 
1. Complete all steps outlined in Daily Husbandry Practices 
2. To a clean cage apply: 
a. Bedding 
b. Clean mouse house 
c. Clean wire lid 
i. Within wire lid place: 
1. Feed 
2. Clean water bottle containing distilled water 
d. Clean microisolator lid with a fresh filter 
3. Weigh mice and record by ear-tag number 
4. Transfer mice to the clean cage 
5. Transfer cage card to the clean cage 
6. Transport soiled cages outside the room to sink or dishwasher (using sanitize 
cycle) 
a. Hand-wash cages and cage accessories with Liquinox detergent 
b. Rinse with Clidox disinfectant 
c. Rinse with ultra-purified water 
d. Place cages on bench cover, on cage rack and allow to air dry 
e. Once dry, reassemble cages with a new filter and leave on cage rack 
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APPENDIX C 
 
 
SDF IMAGING EXPERIMENTAL CHECKLIST 
 
 
 
Figure 33. SDF imaging experimental checklist. This checklist was used when recording muscular branch 
artery functional hyperemia in healthy and ischemic mice. 
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FEMORAL ARTERY LIGATION CHECKLIST 
 
 
 
Figure 34. Femoral Artery Ligation Checklist. Checklist used during femoral artery ligation surgeries. 
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FEMORAL ARTERY RESECTION CHECKLIST 
 
 
 
Figure 35. Femoral Artery Resection Checklist. Checklist used during femoral artery resection surgeries. 
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APPENDIX F 
 
 
MUSCULAR BRANCH FUNCTIONAL HYPEREMIA DATA FOR HEALTHY MICE 
 
Table 1. Muscular branch functional hyperemia data for healthy mice. 
 
Mouse Order Imaged Limb Stimulation 
Frequency (Hz) 
Muscular Branch 
Arterial Diameter (µm) 
1 First Left 0 59.637 
1 Second Right 0 63.503 
2 First Right 0 53.277 
2 Second Left 0 74.71 
3 First Right 0 63.07 
3 Second Left 0 63.53 
4 First Left 0 64.91 
4 Second Right 0 69.68 
5 First Right 0 68.12 
5 Second Left 0 68.02 
1 First Left 2 91.36 
1 Second Right 2 81.53 
2 First Right 2 84.3 
2 Second Left 2 87.3 
3 First Right 2 93.56 
3 Second Left 2 97.67 
4 First Left 2 112.62 
4 Second Right 2 90.69 
5 First Right 2 91.75 
5 Second Left 2 82.2 
1 First Left 4 122.66 
1 Second Right 4 90.74 
2 First Right 4 97.37 
2 Second Left 4 97.95 
3 First Right 4 109.45 
3 Second Left 4 131.25 
4 First Left 4 136.62 
4 Second Right 4 105.71 
5 First Right 4 127.36 
5 Second Left 4 107.15 
1 First Left 8 118.373 
1 Second Right 8 110.443 
2 First Right 8 100.55 
2 Second Left 8 100.283 
3 First Right 8 100.05 
3 Second Left 8 125.13 
4 First Left 8 134.6 
4 Second Right 8 139.53 
5 First Right 8 129.5 
5 Second Left 8 125.4 
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MUSCULAR BRANCH FUNCTIONAL HYPEREMIA DATA FOR LIGATED MICE 
 
Table 2. Muscular branch functional hyperemia data for ligated mice. 
 
Mouse Surgery Type Stimulation 
Frequency (Hz) 
Muscular Branch 
Arterial Diameter 
(µm) 
Vasodilation 
(% Increase) 
1 Sham 0 58.45 . 
2 Sham 0 69.52 . 
3 Sham 0 59.08 . 
4 Sham 0 62.14 . 
5 Sham 0 54.5 . 
6 Sham 0 64.4 . 
1 Sham 2 78.42 34.16595381 
2 Sham 2 93.77 34.88204833 
3 Sham 2 73.4 24.23832092 
4 Sham 2 96.49 55.2784036 
5 Sham 2 85.01 55.98165138 
6 Sham 2 104.95 62.96583851 
1 Sham 4 62.15 6.330196749 
2 Sham 4 111.69 60.65880322 
3 Sham 4 66.28 12.18686527 
4 Sham 4 95.16 53.13807531 
5 Sham 4 75.19 37.96330275 
6 Sham 4 104.31 61.97204969 
1 Sham 8 102.7 75.70573139 
2 Sham 8 103.91 49.46777906 
3 Sham 8 102.68 73.79823968 
4 Sham 8 109.26 75.82877374 
5 Sham 8 109.44 100.8073394 
6 Sham 8 107.6 67.08074534 
1 Ligation 0 66.72 . 
2 Ligation 0 82.38 . 
3 Ligation 0 79.72 . 
4 Ligation 0 68.15 . 
5 Ligation 0 59.5 . 
6 Ligation 0 75.63 . 
1 Ligation 2 90.26 35.28177458 
2 Ligation 2 116.99 42.01262442 
3 Ligation 2 95.68 20.02007025 
4 Ligation 2 95.22 39.72120323 
5 Ligation 2 81.46 36.90756303 
6 Ligation 2 134.37 77.66759223 
1 Ligation 4 70.94 6.324940048 
2 Ligation 4 93.97 14.06894877 
3 Ligation 4 92.16 15.60461616 
4 Ligation 4 80.82 18.59134263 
5 Ligation 4 90.91 52.78991597 
6 Ligation 4 123.13 62.80576491 
1 Ligation 8 115.62 73.29136691 
2 Ligation 8 120.64 46.44331148 
3 Ligation 8 108.98 36.70346212 
4 Ligation 8 112.52 65.10638298 
5 Ligation 8 120.34 102.2521008 
6 Ligation 8 141.95 87.69007008 
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MUSCULAR BRANCH FUNCTIONAL HYPEREMIA DATA FOR RESECTED MICE 
 
Table 3. Muscular branch functional hyperemia data for resected mice. 
 
Mouse Surgery Type Stimulation 
Frequency (Hz) 
Muscular 
Branch Arterial 
Diameter (µm) 
Vasodilation 
(% Increase) 
1 Sham 0 64.82 . 
2 Sham 0 61.48 . 
3 Sham 0 71.11 . 
4 Sham 0 55.66 . 
1 Sham 2 89.66 38.3215057 
2 Sham 2 99.98 62.6219909 
3 Sham 2 107.79 51.582056 
4 Sham 2 106.84 91.9511319 
1 Sham 4 102.42 58.006788 
2 Sham 4 112.78 83.4417697 
3 Sham 4 123.76 74.0402194 
4 Sham 4 106.61 91.5379087 
1 Sham 8 105.48 62.7275532 
2 Sham 8 118.23 92.3064411 
3 Sham 8 124.18 74.6308536 
4 Sham 8 104.35 87.4775422 
1 Resection 0 43.56 . 
2 Resection 0 64.28 . 
3 Resection 0 43.48 . 
4 Resection 0 61.35 . 
1 Resection 2 99.17 127.662994 
2 Resection 2 113.29 76.2445551 
3 Resection 2 92.36 112.419503 
4 Resection 2 95.29 55.3219234 
1 Resection 4 83.27 91.1616162 
2 Resection 4 109.37 70.1462352 
3 Resection 4 93.82 115.777369 
4 Resection 4 106.95 74.3276284 
1 Resection 8 95.99 120.362718 
2 Resection 8 112.01 74.253267 
3 Resection 8 109.75 152.414903 
4 Resection 8 103.4 68.5411573 
 
